Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients?

Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients?

Aims:The results of randomized clinical trials evaluating the effects of tocilizumab in patients with patients are inconsistent. We aimed to investigate the reliability of pre-treatment levels of prognostic nutritional index (PNI), C-reactive protein (CRP)/albumin ratio (CAR), systemic immune-inflam...

Full description

Bibliographic Details
Main Authors: Mehmet Nur Kaya, Duygu Tecer, Muhammet Çınar, Fahrettin Bıçakcı, Emre Tekgöz, Seda Çolak, Sedat Yılmaz
Format: Article
Language:English
Published: Galenos Publishing House 2023-12-01
Series:Gülhane Tıp Dergisi
Subjects:
covid-19
tocilizumab
prognostic nutritional index
c-reactive protein/albumin ratio
systemic immune-inflammatory index
Online Access: http://gulhanemedj.org/archives/archive-detail/article-preview/can-pre-treatment-inflammatory-biomarker-levels-pr/63820

Internet

http://gulhanemedj.org/archives/archive-detail/article-preview/can-pre-treatment-inflammatory-biomarker-levels-pr/63820

Similar Items